EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway

Emine Sarman iD, Halil Asci iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27052110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Emine Sarman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Türkiye. Hauptthemen laut MEDLINE: Apoptosis, Glucosides, Chemical and Drug Induced Liver Injury, Methotrexate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Afyonkarahisar Health Sciences University Scientific Research Project Unit (AFSU-BAP) provided financial support for the study, Afyonkarahisar Health Sciences University Scientific Research Project Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX), an effective immunosuppressive and antiproliferative agent, is clinically restricted by its hepatotoxic potential through oxidative stress, inflammation, and apoptosis. Dapagliflozin (DAPA), a sodium–glucose cotransporter 2 inhibitor, exhibits antioxidant and anti-inflammatory actions. This study investigated the hepatoprotective effects of DAPA against MTX-induced acute liver injury. Thirty-two female Wistar albino rats were divided into four groups (n = 8): Control, MTX (20 mg/kg), MTX + DAPA (MTX + DAPA 10 mg/kg/day for 10 days), and DAPA. Liver samples were examined histologically, immunohistochemically (Nuclear factor NF-kappa-B p65 subunit (NF-κB p65), Tumor necrosis factor alpha (TNF-α), Interleukin 1 beta (IL-1β), Caspase (Cas)-3, Vascular endothelial growth factor (VEGF)), molecularly (Reverse transcription–polymerase chain for Bcl-2-associated X protein (Bax), B-cell lymphoma 2 (Bcl-2), Cytochrome C (Cyt-C), Apoptotic peptidase activating factor 1 (Apaf-1), Cas-9, Cas-3, Cas-12), and biochemically (total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI)). MTX induced severe hepatic injury with congestion, sinusoidal dilatation, and inflammatory infiltration, accompanied by upregulation of NF-κB, TNF-α, IL-1β, Bax, Cyt-C, Apaf-1, Cas-9, Cas-3, and Cas-12 and reduced Bcl-2. DAPA co-treatment significantly restored hepatic structure, suppressed inflammatory and apoptotic markers, and normalized VEGF expression, indicating reduced pathological angiogenesis. Although DAPA did not fully reverse MTX-induced weight loss, it effectively mitigated hepatocellular damage. DAPA protects against MTX-induced liver injury by inhibiting NF-κB/TNF-α/IL-1β-mediated inflammation, modulating Bax/Bcl-2–Cyt-C–Cas-dependent apoptosis, and balancing VEGF-driven angiogenesis. DAPA may thus serve as a promising hepatoprotective adjunct in MTX therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisGlucosidesChemical and Drug Induced Liver InjuryMethotrexateSignal TransductionBenzhydryl CompoundsAnimalsFemaleRatsRats, WistarProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinOxidative StressLiverCaspase 9Caspase 3

Stichwörter der Autor:innen

NF-κBVEGFacute liver injuryapoptosissodium–glucose cotransporter 2 inhibitor

Substanzen

GlucosidesMethotrexateProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinBenzhydryl CompoundsdapagliflozinBcl2 protein, ratCaspase 9Caspase 3

Autor:innen und Institutionen

  • Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Türkiye.
  • Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta 32260, Türkiye.

ORCID-Profile: Emine Sarman, Halil Asci

Förderung

  • Afyonkarahisar Health Sciences University Scientific Research Project Unit (AFSU-BAP) provided financial support for the study
  • Afyonkarahisar Health Sciences University Scientific Research Project Unit

Zitieren

APA

Sarman, E., & Asci, H. (2026). Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052110

Vancouver

Sarman E, Asci H. Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052110

BibTeX
@article{Sarman2026,
  author = {Sarman, Emine and Asci, Halil},
  title = {Cellular Anti-Apoptotic Effects of Dapagliflozin in Methotrexate-Induced Liver Toxicity: Bax/Bcl-2/Cyt-C/Cas-9/Cas-3 Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27052110}
}
Kostenlos starten →